Decision Guidelines for Prophylactic Replacement of Björk-Shiley Convexo-Concave Heart Valves: Impact on Clinical Practice

Circulation

Volumn 109, Issue 17, 2004, Pages 2092-2096

  Van Gorp, M J ^a   Steyerberg, E W ^b   Van Der Graaf, Y ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Follow up studies; Prevention; Prosthesis; Surgery; Valves

Indexed keywords

ADULT; AGED; ARTICLE; BJOERK SHILEY VALVE PROSTHESIS; CALCULATION; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SAFETY; SURVIVAL; TREATMENT INDICATION;

ADULT; AGED; CAUSE OF DEATH; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; EMERGENCIES; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 2442589796     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000125853.51637.C8     Document Type: Article

References (24)

1. Birkmeyer JD, Marrin CA, O'Connor GT. Should patients with Bjork-Shiley valves undergo prophylactic replacement? Lancet. 1992;340: 520-523.
2. Ericsson A, Lindblom D, Semb G, et al. Strut fracture with Bjork-Shiley 70 degrees convexo-concave valve: an international multi-institutional follow-up study. Eur J Cardiothorac Surg. 1992;6:339-346.
3. Lindblom D, Bjork VO, Semb BK. Mechanical failure of the Bjork-Shiley valve: incidence, clinical presentation, and management. J Thorac Cardiovasc Surg. 1986;92:894-907.
4. Omar RZ, Morton LS, Halliday DA, et al. Outlet strut fracture of Bjork-Shiley convexo concave heart valves: the UK Cohort Study. Heart. 2001;86:57-62.
5. van der Graaf Y, de Waard F, van Herwerden LA, et al. Risk of strut fracture of Björk-Shiley valves. Lancet. 1992;339:257-261.
6. van der Meulen JH, Steyerberg EW, van der Graaf Y, et al. Age thresholds for prophylactic replacement of Björk-Shiley convexo-concave heart valves: a clinical and economic evaluation. Circulation. 1993;88:156-164.
7. Kallewaard M, Algra A, van der Graaf Y. Welder identity, weld date, and the risk of outlet strut fracture in Björk-Shiley convexo-concave valves: the Dutch Cohort Study. Heart. 1996;76:510-512.
8. Steyerberg EW, van der Meulen JH, van Herwerden LA, et al. Prophylactic replacement of Björk-Shiley convexo-concave heart valves: an easy-to-use tool to aid decision-making in individual patients. Heart. 1996;76:264-268.
9. Kallewaard M, Algra A, Defauw J, et al. Which manufacturing characteristics are predictors of outlet strut fracture in large sixty-degree Björk-Shiley convexo-concave mitral valves? The Bjork-Shiley Study Group. J Thorac Cardiovasc Surg. 1999;117:766-775.
10. Steyerberg EW, Kallewaard M, van der Graaf Y, et al. Decision analyses for prophylactic replacement of the Björk-Shiley convexo-concave heart valve: an evaluation of assumptions and estimates. Med Decis Making. 2000;20:20-32.
11. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342: 1317-1322.
12. Woolf SH, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318: 527-530.
13. Kallewaard M, Algra A, Defauw J, et al. Long-term survival after valve replacement with Björk-Shiley CC valves: Björk-Shiley Study Group. Am J Cardiol. 2000;85:598-603.
14. Cleveland WS. The Elements of Graphing Data. Summit, NJ: Hobart Press; 1994.
15. Mansur AJ, Dal Bo CM, Fukushima JT, et al. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J. 2001;141:78-86.
16. Ivert TS, Dismukes WE, Cobbs CG, et al. Prosthetic valve endocarditis. Circulation. 1984;69:223-232.
17. Tomos MP, Permanyer-Miralda G, Olona M, et al. Long-term complications of native valve infective endocarditis in non-addicts a 15-year follow-up study. Ann Intern Med. 1992;117:567-572.
18. Blot WJ, Omar RZ, Kallewaard M, et al. Risks of fracture of Björk-Shiley 60 degree convexo-concave prosthetic heart valves: long-term cohort follow up in the UK, Netherlands and USA. J Heart Valve Dis. 2001;10: 202-209.
19. Oxenham H, Bloomfield P, Wheatley DJ, et al. Twenty year comparison of a Björk-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003;89:715-721.
20. van Gorp MJ, Steyerberg EW, Kallewaard M, et al. Clinical prediction rule for 30-day mortality in Bjork-Shiley convexo-concave valve replacement. J Clin Epidemiol. 2003;56:1006-1012.
21. Kallewaard M, Defauw J, van der Graaf Y. Psychological distress among recipients of Björk-Shiley convexo-concave valves: the impact of information. Heart. 1997;78:577-580.
22. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA. 1997;277: 488-494.
23. Shekelle PG, Ortiz E, Rhodes S, et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA. 2001;286:1461-1467.
24. Garfield FB, Garfield JM. Clinical judgment and clinical practice guidelines. Int J Technol Assess Health Care. 2000;16:1050-1060.